NCT00117624View on ClinicalTrials.gov

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2002

Study Completion Date

December 31, 2003

Conditions
Anemia
Interventions
DRUG

darbepoetin alfa

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00117624 - A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy | Biotech Hunter | Biotech Hunter